Edit this Company edit this company

Research & Development

  
USA

http://www.kingpharm.com

Products

News and Blogs

Total : 613   View more »

InterMune Inc Sells Actimmune to Vidara for 55 Mi

...by visiting www.actimmune.com. About InterMune InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. In pulmonology...

Johnson & Johnson Won't Stay Down Long - Here's A Bullish Income Play - Seeking Alpha

< strong > By < a href='http://empoweredinvestingnow.com/' > John Mylant < /a > : < /strong > < p > Johnson & amp; Johnson ( < a href='http://seekingalpha.com/symbol/jnj' title='Johnson & Johnson' > JNJ < /a > ) is struggling but we do not think the stock will stay down for a long period of time.

Takeda Included in the FTSE4Good Global Index for the Eighth Consecutive Year (May 21, 2012) | 2012

Osaka, Japan, May 21, 2012 - Takeda Pharmaceutical Company Limited (“Takeda”) announced today that it has been included for the eighth consecutive year in “the FTSE4Good Global Index of the FTSE4Good Index Series”, which is one of the world’s premier indices for Socially Responsible Investment

Looking Away As You Get Needle Does Lower Pain, Study Shows

...Disease Rebif Recalls Reference Relafen Relaxation Therapy Relenza Religion Remicade Research & Development Respiratory Problems: Flu Or Pneumonia Respiratory Problems: Misc. Restasis Retirement Planning...

Biotech Industry Hotbed of Merger & Acquisition Speculation | SYS-CON MEDIA

...injection of the company's PLacental eXpanded (PLX) cells. Alexza is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions...